From left: James Greenwood, president and CEO of the Biotechnology Innovation Organisation; Charles Li Xiaojia, chief executive of Hong Kong Exchanges and Clearing; Carlson Tong, chairman of the Securities and Futures Commission; Hong Kong Financial Secretary Paul Chan Mo-po; and Chow Chung-kong, chairman of HKEX, at the HKEX Biotech Summit. Photo: Edward Wong

Hong Kong plans to overtake Nasdaq as listing destination of choice for Chinese biotech firms

Chief executive Charles Li Xiaojia says listings could start as early as this summer after new rules come into effect

Topic |   IPO

TOP PICKS

From left: James Greenwood, president and CEO of the Biotechnology Innovation Organisation; Charles Li Xiaojia, chief executive of Hong Kong Exchanges and Clearing; Carlson Tong, chairman of the Securities and Futures Commission; Hong Kong Financial Secretary Paul Chan Mo-po; and Chow Chung-kong, chairman of HKEX, at the HKEX Biotech Summit. Photo: Edward Wong
READ FULL ARTICLE